Geron awarded cash grants through Obamacare for now defunct embryonic stem cell program
In my previous post I detailed how devastating it is to the embryonic stem cell industry that Geron Corporation has abruptly abandoned it. Now only one other U.S. company, Advanced Cell Technology, is running a clinical trial using embryonic stem cells with the hope of a commercial payoff.
Jill Stanek is a nurse turned speaker, columnist and blogger, a national figure in the effort to protect both preborn and postborn innocent human life.